Search Count: 12
![]() |
Crystal Structure Of The Hiv Capsid Hexamer Bound To The Small Molecule Long-Acting Inhibitor, Gs-6207
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2020-07-01 Classification: VIRAL PROTEIN Ligands: QNG |
Organism: Human immunodeficiency virus 1
Method: X-RAY DIFFRACTION
Release Date: 2020-07-01
Ligands: QNG
![]() |
Ask1 Kinase Domain Complex With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.25 Å Release Date: 2018-09-19 Classification: TRANSFERASE/INHIBITOR Ligands: KK7 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-09-19
Ligands: KK7
![]() |
Ask1 Kinase Domain Complex With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.10 Å Release Date: 2018-09-19 Classification: TRANSFERASE/INHIBITOR Ligands: KK8 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-09-19
Ligands: KK8
![]() |
Ask1 Kinase Domain Complex With Inhibitor
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.39 Å Release Date: 2018-09-19 Classification: TRANSFERASE/INHIBITOR Ligands: S0L |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2018-09-19
Ligands: S0L
![]() |
Structure Determination Of A Potent, Selective Antibody Inhibitor Of Human Mmp9 (Gs-5745 Bound To Mmp-9)
Organism: Oryctolagus cuniculus, Homo sapiens
Method: X-RAY DIFFRACTION Resolution:3.00 Å Release Date: 2017-03-15 Classification: hydrolase/hydrolase inhibitor Ligands: ZN, CA, NCO |
Organism: Oryctolagus cuniculus, Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-15
Ligands: ZN, CA, NCO
![]() |
Structure Determination Of A Potent, Selective Antibody Inhibitor Of Human Mmp9 (Apo Mmp9)
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.70 Å Release Date: 2017-03-01 Classification: hydrolase/hydrolase inhibitor Ligands: ZN, CA |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-03-01
Ligands: ZN, CA
![]() |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 3) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.30 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 7HG |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-25
Ligands: 7HG
![]() |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 5) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:2.00 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78E |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-25
Ligands: 78E
![]() |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 6) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.40 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78R |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-25
Ligands: 78R
![]() |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 7) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.48 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 78X |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-25
Ligands: 78X
![]() |
Discovery Of A Potent Cyclophilin Inhibitor (Compound 8) Based On Structural Simplification Of Sanglifehrin A
Organism: Homo sapiens
Method: X-RAY DIFFRACTION Resolution:1.50 Å Release Date: 2017-01-25 Classification: isomerase/isomerase inhibitor Ligands: 838, SO4 |
Organism: Homo sapiens
Method: X-RAY DIFFRACTION
Release Date: 2017-01-25
Ligands: 838, SO4
![]() |
Idelalisib Bound To The P110 Subunit Of Pi3K Delta
Organism: Mus musculus
Method: X-RAY DIFFRACTION Resolution:2.43 Å Release Date: 2015-02-04 Classification: Transferase/transferase inhibitor Ligands: 40L |
Organism: Mus musculus
Method: X-RAY DIFFRACTION
Release Date: 2015-02-04
Ligands: 40L
